Moreover, TLE3 and AR binding at this region occurs at the same regulatory element described previously to be relevant in the regulation of GR in prostate cancer progression (Shah et al., 2017) (Figure 4—figure supplement 1A). The gene discussed is AR; the disease is prostate carcinoma.